Understanding the role of the mineralocorticoid receptor in diabetic cardiac myopathy?
- Research Opportunity
- Honours students
- Number of Honour Places Available
- Department / Centre
- Baker Department of Cardiometabolic Health
|Associate Professor Morag Youngfirstname.lastname@example.org||385321111||Personal web page|
Summary Patients with diabetes are disproportionally affected by the incidence of cardiovascular disease (CVD); diabetic cardiac myopathy (DCM) affects ~20-25% of patients with diabetes. New therapies are needed to address this significant unmet need in the diabetic population. Mineralocorticoid receptor (MR) antagonists (MRA) are protective in DCM but side effects caused by poor kidney function limit its use in the clinic. This project will test a new MRA in development with an improved safety profile in a model of DCM. Diabetic mice (STZ model) will be given vehicle, a standard MRA or a novel MRA and the impact on cardiac remodelling, cardiac and renal function and diabetic metabolic endpoints will be investigated to determine any benefit of the new MRA for DCM. Techniques will include animal models, immunohistochemistry, cell culture RNA and protein isolation, RT PCR and western blot techniques. If time permits, bioinformatic analysis of data bases of patients with cardiac disease.
School Research Themes
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.
Department / Centre
Baker Department of Cardiometabolic Health
MDHS Research library
Explore by researcher, school, project or topic.